Madrigal Pharmaceuticals (NASDAQ:MDGL) Reaches New 52-Week High on Analyst Upgrade
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report)’s share price reached a new 52-week high during trading on Tuesday after B. Riley raised their price target on the stock from $460.00 to $560.00. B. Riley currently has a buy rating on the stock. Madrigal Pharmaceuticals traded as high as $459.54 and last traded at $458.97, […]
More Stories
Indiana House Passes New Congressional Map Favoring Republicans
By Arjun Singh The Indiana House of Representatives on Dec. 5 passed a bill that would revise the state’s maps...
Economists Forecast Stronger US Growth, Lingering Inflation in 2026
By Tom Ozimek The U.S. economy will grow faster next year than previously projected and inflationary pressures will tick down,...
Noem Says US Travel Ban to Expand to Over 30 Countries
By Aldgra Fredly Homeland Security Secretary Kristi Noem said on Dec. 4 that the Trump administration is looking to increase...
Supreme Court Will Hear Trump’s Birthright Citizenship Case
By Matthew Vadum The U.S. Supreme Court decided on Dec. 5 to review whether President Donald Trump’s executive order ending birthright...
The Best Food Scene You Don’t Know About Is in Buffalo, New York
By Adam Reiner, Bloomberg News Buffalo might be synonymous with hot wings, but there’s a less heralded bar staple that...
The Best Food Scene You Don’t Know About Is in Buffalo, New York
By Adam Reiner, Bloomberg News Buffalo might be synonymous with hot wings, but there’s a less heralded bar staple that...